G. Mann

发表

Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines

J. Barrett, D. Bishop, G. Giles, 2019, The British journal of dermatology.

From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes

E. Gillanders, J. Aitken, K. Dutton-Regester, 2012, Hereditary Cancer in Clinical Practice.

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12‐month follow‐up results of a randomized controlled trial

S. Menzies, P. Butow, S. Lo, 2020, The British journal of dermatology.

Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers

G. Mann, I. Tomlinson, R. Kefford, 1993, Genes, chromosomes & cancer.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

C. J. Thompson, C. Amos, I. Gorlov, 2022, medRxiv.

Clinical practice guidelines for identification, screening and follow‐up of individuals at high risk of primary cutaneous melanoma: a systematic review

G J Mann, S. Menzies, G. Mann, 2015, The British journal of dermatology.

Predictors of psychological distress among individuals with a strong family history of malignant melanoma

G. Mann, P. Butow, J. Simpson, 2007, Clinical genetics.

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

S. Puig, E. Gillanders, D. Elder, 2010, Journal of the National Cancer Institute.

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia

S. Puig, D. Elder, N. Hayward, 2021, Genetics in Medicine.

Sentinel lymph node biopsy rates in Victoria, 2018 and 2019

A. Spillane, F. Rapport, M. Henderson, 2022, Medical Journal of Australia.